GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TaiMed Biologics Inc (ROCO:4147) » Definitions » Cyclically Adjusted Book per Share

TaiMed Biologics (ROCO:4147) Cyclically Adjusted Book per Share : NT$16.71 (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is TaiMed Biologics Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

TaiMed Biologics's adjusted book value per share for the three months ended in Mar. 2024 was NT$15.425. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is NT$16.71 for the trailing ten years ended in Mar. 2024.

During the past 12 months, TaiMed Biologics's average Cyclically Adjusted Book Growth Rate was 5.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2024-05-26), TaiMed Biologics's current stock price is NT$87.20. TaiMed Biologics's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was NT$16.71. TaiMed Biologics's Cyclically Adjusted PB Ratio of today is 5.22.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of TaiMed Biologics was 8.14. The lowest was 3.49. And the median was 4.97.


TaiMed Biologics Cyclically Adjusted Book per Share Historical Data

The historical data trend for TaiMed Biologics's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TaiMed Biologics Cyclically Adjusted Book per Share Chart

TaiMed Biologics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 14.27 15.40 16.44

TaiMed Biologics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.80 16.08 16.35 16.44 16.71

Competitive Comparison of TaiMed Biologics's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, TaiMed Biologics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TaiMed Biologics's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TaiMed Biologics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where TaiMed Biologics's Cyclically Adjusted PB Ratio falls into.



TaiMed Biologics Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, TaiMed Biologics's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=15.425/131.7762*131.7762
=15.425

Current CPI (Mar. 2024) = 131.7762.

TaiMed Biologics Quarterly Data

Book Value per Share CPI Adj_Book
201406 8.984 100.560 11.773
201409 0.000 100.428 0.000
201412 8.330 99.070 11.080
201503 8.107 99.621 10.724
201506 7.628 100.684 9.984
201509 6.874 100.392 9.023
201512 19.530 99.792 25.789
201603 19.370 100.470 25.406
201606 19.117 101.688 24.773
201609 18.990 101.861 24.567
201612 18.590 101.863 24.049
201703 18.424 102.862 23.603
201706 17.998 103.349 22.949
201709 17.566 104.136 22.229
201712 16.900 104.011 21.411
201803 17.388 105.290 21.762
201806 17.841 106.317 22.113
201809 16.523 106.507 20.443
201812 16.000 105.998 19.891
201903 15.858 107.251 19.484
201906 15.565 108.070 18.979
201909 14.321 108.329 17.421
201912 14.017 108.420 17.037
202003 13.749 108.902 16.637
202006 13.886 108.767 16.823
202009 13.718 109.815 16.461
202012 13.349 109.897 16.007
202103 13.388 111.754 15.787
202106 13.014 114.631 14.960
202109 12.727 115.734 14.491
202112 11.491 117.630 12.873
202203 11.075 121.301 12.031
202206 10.813 125.017 11.398
202209 10.726 125.227 11.287
202212 10.596 125.222 11.151
202303 10.317 127.348 10.676
202306 10.315 128.729 10.559
202309 10.301 129.860 10.453
202312 9.997 129.419 10.179
202403 15.425 131.776 15.425

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


TaiMed Biologics  (ROCO:4147) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

TaiMed Biologics's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=87.20/16.71
=5.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of TaiMed Biologics was 8.14. The lowest was 3.49. And the median was 4.97.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


TaiMed Biologics Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of TaiMed Biologics's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


TaiMed Biologics (ROCO:4147) Business Description

Industry
Traded in Other Exchanges
N/A
Address
No. 607, Ruiguang Road, 3rd Floor, Neihu District, Taipei, TWN, 11492
TaiMed Biologics Inc is a Taiwan-based biotechnology company. It is engaged in the discovery, development, and delivery of medicines for infectious disease. It capitalizes on its intellectual, extensive expertise, and management resources to develop a health-care product pipeline that benefits patients, rewards investors, and propels to prominence in the biotechnology industry. The company's products pipeline includes TMB-365, VRC07-523LS, and others.

TaiMed Biologics (ROCO:4147) Headlines

No Headlines